Skip to Content

A LGX 50mg (Braftovi 50 mg)

Generic Name: encorafenib

Pill with imprint A LGX 50mg is Beige / Orange, Capsule-shape and has been identified as Braftovi 50 mg. It is supplied by Array BioPharma Inc..

Braftovi is used in the treatment of colorectal cancer; melanoma, metastatic and belongs to the drug class multikinase inhibitors. Braftovi 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A LGX 50mg

Braftovi

Generic Name
encorafenib
Imprint
A LGX 50mg
Strength
50 mg
Color
Beige / Orange
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Array BioPharma Inc.
National Drug Code (NDC)
70255-0020
Inactive Ingredients
copovidone, poloxamer 188, microcrystalline cellulose, succinic acid, silicon dioxide, magnesium stearate, titanium dioxide, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, shellac, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.